Literature DB >> 35518797

Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuse.

Onyedika J Ilonze1, Chioma O Enyi2, Chibuzo C Ilonze3.   

Abstract

Bodybuilders often use anabolic-androgenic steroids to improve performance. We report a case of a 30-year-old male bodybuilder with anabolic-androgen steroid abuse while getting ready for a bodybuilding contest. He had New York Heart Association class IV heart failure, severe nonischemic dilated cardiomyopathy, new-onset atrial fibrillation, cardiogenic pulmonary edema, and acute respiratory distress requiring mechanical ventilation. After 6 months of heart failure guideline-directed medical therapy, cessation of anabolic steroids, and maintenance of sinus rhythm, his ejection fraction improved.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Anabolic-androgen steroid; guideline-directed medical therapy; heart failure; nonischemic cardiomyopathy

Year:  2022        PMID: 35518797      PMCID: PMC9037463          DOI: 10.1080/08998280.2022.2039496

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  14 in total

1.  Steroid-induced cardiomyopathy.

Authors:  Hui-Chen Han; Omar Farouque; David L Hare
Journal:  Med J Aust       Date:  2015-09-07       Impact factor: 7.738

Review 2.  Anabolics and cardiomyopathy in a bodybuilder: case report and literature review.

Authors:  Christoph Ahlgrim; Maya Guglin
Journal:  J Card Fail       Date:  2009-02-10       Impact factor: 5.712

3.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael T Lu; Udo Hoffmann; Harrison G Pope
Journal:  Circulation       Date:  2017-05-23       Impact factor: 29.690

4.  Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.

Authors:  Massimo Montisci; Rafi El Mazloum; Giovanni Cecchetto; Claudio Terranova; Santo Davide Ferrara; Gaetano Thiene; Cristina Basso
Journal:  Forensic Sci Int       Date:  2011-11-01       Impact factor: 2.395

5.  Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease.

Authors:  Maged Y Z Youssef; Ahmed Alqallaf; Nabila Abdella
Journal:  BMJ Case Rep       Date:  2011-06-30

6.  Cardiomyopathy induced by anabolic-androgenic steroid abuse.

Authors:  Orlando Garner; Alfredo Iardino; Ana Ramirez; Maty Yakoby
Journal:  BMJ Case Rep       Date:  2018-07-23

7.  Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder.

Authors:  Miguel Bispo; Ana Valente; Rosário Maldonado; Rui Palma; Helena Glória; João Nóbrega; Paula Alexandrino
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

8.  Left ventricular assist device for ventricular recovery of anabolic steroid-induced cardiomyopathy.

Authors:  Jessica G Y Luc; Holger Buchholz; Daniel H Kim; Roderick G G MacArthur
Journal:  J Surg Case Rep       Date:  2018-08-15

9.  Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete.

Authors:  Edward T Ha; Michael L Weinrauch; Jeffrey Brensilver
Journal:  Cureus       Date:  2018-09-17

10.  Strong muscles, weak heart: testosterone-induced cardiomyopathy.

Authors:  Sarah Doleeb; Ann Kratz; Monica Salter; Vinay Thohan
Journal:  ESC Heart Fail       Date:  2019-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.